Lars Rebien Sørensen to join the board of directors of Novo Nordisk A/S
Novo Nordisk A/S announced earlier today that Lars Rebien Sørensen, Chair of the Novo Nordisk Foundation, will join its board of directors, initially as an observer....
Tag : pharmaceutical industry
Adicet Bio Appoints Michael Grissinger to the Board of Directors
–Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions– Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage...
AscellaHealth Q1 2025 Specialty & Rare Pipeline Digest™
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty & Rare Pipeline Digest™, the industry’s most comprehensive digital...
Domain Therapeutics Unveils DT-9046 as Oral Drug for Inflammation
Domain Therapeutics (“Domain” or “the Company”), the GPCR experts harnessing deep receptor biology to develop breakthrough treatments for patients, today announces it has nominated and...
Orbia Releases 2024 Annual Impact Report
Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA) has released its 16th annual report detailing the company’s 2024 business performance and progress against its environmental, social...
Purdue-led panel to explore pharmaceutical transformations
President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma Purdue University’s position as a key...
The Future of Medicine: VoxCell BioInnovation on All Access
All Access with Andy Garcia explores how VoxCell BioInnovation Inc. is revolutionizing drug development with 3D bioprinting, paving the way for personalized medicine and an end to...
AscellaHealth Expands Leadership to Drive Growth and Innovation
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA,...
Avanzanite Bioscience Appoints Chief Financial Officer
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces today the appointment of Abdelghani (Abdel)...